How To Extrapolate For Biosimilars: New Guidance From International Regulators’ Forum
Executive Summary
The international regulators’ forum, the IPRF, has produced guidance on the issues associated with extrapolation that national regulatory bodies should take into consideration when evaluating biosimilar medicines submitted for approval.